Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Medulloblastoma × sonidegib × Clear all

Phase

Status

Sponsor Class

INDUSTRY 3 OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Medulloblastoma 1

Interventions

Vincristine 7 Cyclophosphamide 7 Cisplatin 6 Radiotherapy 5 Platinum 4 Filgrastim 4 Etoposide 4 Carboplatin 4 1,2-diaminocyclohexaneplatinum II citrate 4 Radiation 3 Lomustine 3 Granulocyte Colony-Stimulating Factor 3 merphos 2 Specimen Handling 2 Methotrexate 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 sonidegib 1 sodium thiosulfate 1 silmitasertib 1 sargramostim 1 ribociclib 1 palbociclib 1 omburtamab I-131 1 lonafarnib 1 laromustine 1 emvododstat 1 azurin (50-77) 1 Valproic Acid 1 Triiodothyronine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04402073 2025-10-23

PersoMed-I

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡